|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial显示文摘 | Paul Rutgeerts Gert van Assche Séverine Vermeire Geert D’Haens Filip Baert Maja Noman Isolde Aerden Gert de Hertogh Karel Geboes Martin Hiele Andre D’Hoore Freddy Penninckx | 2005 | Gastroenterology2005，，4： | 2 |
| 2 | Description of the Entropy algorithm as applied in the Datex-Ohmeda S/5 Entropy Module显示文摘 | Vierti(o)-Oja H Maja V S(a)kel(a) M | 2004 | Acta Anaesthesiol Scand2004，48，2： | 1 |
| 3 | Kinetics of hydrolysis of monofunctional and bifunctional monochloro-s-triazine reactive dyes显示文摘 | MAJA Klan(c)nik MARIJA Goren(s)ek | 1997 | Dyes and Pigments1997，33，4： | 1 |
| 4 | A fuzzy habitat suitability index forPopulus euphratica in the Northern Amudarya delta(Uzbekistan)显示文摘 | NADJA R MAJA S MICHAEL M | 2005 | Ec-ological Modelling2005，184，： | 1 |
| 5 | Prognostic impact of plasma lipids in patients with lower respiratory tract infections -an observational study显示文摘 | MAJA G MIRJAM C C DAIANA S | 2009 | Swiss Med Weekly2009，139，1112： | 1 |
| 6 | Toward a Biochmical Understanding of human Intervertebral Disc Degeneration and Herniation,Contributions of NitricOxider,Interleukins,Prostaglandin E2,and Matrix Metalloproteinases显示文摘 | James D K Maja S R McLntyre L A | 1997 | Spine1997，22，10： | 1 |
| 7 | Oxidation of Hydrogen on WC at Low Temperature显示文摘 | Bodoardo S Maja A M Penazzi A N | 1997 | Electrochimica Acta1997，42，17： | 1 |
| 8 | Enzymatic synthesis of sugar fatty acid esters in organic solvent and in supercritical carbon dioxide and their antimicrobial activity显示文摘 | Maja Habulin Sǎsǎ Sabeder Zeljko Knez | | 0，，： | 1 |
| 9 | Oxidation of hy- drogen on WC at low temperature 显示文摘 | Bodoardo S Maja M Penazzi N Henn FEG | 1997 | Electrochim Acta1997，42，17： | 1 |
| 10 | Prog- nostic impact of plasma lipids in patients with lower re- spiratory tract infections -an observational study显示文摘 | Maja G Mirjam C C Daiana S | 2009 | Swiss Med Weekly2009，139，1112： | 1 |
| 11 | DNA methyltransferases controI telomere length and telomere recombination in mammalian cells显示文摘 | Gonzalo S Susan M Maja Okuka | 2006 | Nature Cell Biology2006，8，： | 1 |
| 12 | A fuzzy habitat suitability index for Popu- lus euphratica in the Northern Amud-arya delta (Uzbekistan) 显示文摘 | NADJA R MAJA S MICHAEL M | 2005 | Ecological Modelling2005，184，： | 1 |
| 13 | Prognostic impact of plasma lipids in patients with lower respiratory tract infections -an observational study显示文摘 | MAJA G MIRJAM C C DAIANA S | 2009 | Swiss Med Weekly2009，139，1112： | 1 |
| 14 | Tenomodulin is highly expressed in adipose tissue,increased in obesity, and down-regulated during diet-induced weight loss 显示文摘 | ATSUHITO S MAJA O MARGARETA J | 2009 | The Journal of Clinical Endocrinology and Metabolism2009，94，10： | 1 |
| 15 | A compressibility and compactibility study of real tableting mixtures:The impact of wet and dry granulation versus a direct tableting mixture显示文摘 | Maja S Ilija I Franc V | 2011 | International Journal of Pharmaceutics2011，414，12： | 1 |
| 16 | Synthesis of hexoserelated imidazolidinones:Novel glycation products in the Maillard reaction显示文摘 | (S)TEFICA HORVAT MAJA RO(S)(C)(I) JAROSLAV HORVAT | 1999 | Springer Netherlands1999，，16： | 1 |
| 17 | Immunotherapy:A new standard in the treatment of metastatic clear cell renal cell carcinoma显示文摘Renal cell cancer(RCC)represents 2%-3% of all adulthood cancers and is the most common malignant neoplasm of the kidney(90%).In the mid-nineties of the last century,the standard of treatment for patients with metastatic RCC was cytokines.Sunititib and pazopanib were registered in 2007 and 2009,respectively,and have since been the standard first-line treatment for metastatic clear cell RCC(mccRCC).Renal cell cancer is a highly immunogenic tumor with tumor infiltrating cells,including CD8+T lymphocytes,dendritic cells,natural killer cells(NK)and macrophages.This observation led to the design of new clinical trials in which patients were treated with immunotherapy.With the growing evidence that proangiogenic factors can have immunomodulatory effects on the host’s immune system,the idea of combining angiogenic drugs with immunotherapy has emerged,and new clinical trials have been designed.In the last few years,several therapeutic options have been approved[immunotherapy and immunotherapy/tyrosine kinase inhibitors(TKI)]for the first-line treatment of mccRCC.Nivolumab/ipilimumab is approved for the treatment of patients with intermediate and poor prognoses.Several checkpoint inhibitors(pembrolizumab,nivolumab,avelumab)in combination with TKI(axitinib,lenvatinib,cabozantinib)are approved for the treatment of patients regardless of their International mRCC Database Consortium prognostic group and PD-L1 expression.There is no specific and ideal biomarker that could help in selecting the ideal patient for the appropriate first-line treatment. | Maja Popovic Gorana Matovina-Brko Masa Jovic Lazar S Popovic | 2022 | World Journal of Clinical Oncology2022，13，1： | 1 |
| 18 | Description of the entropy TM algorithm as applied in the Datex-Ohmeda S/5TM Entropy Module显示文摘 | Vierti(o)ja H Maja V S(a)rkel(a) M | 2004 | Acta Anaesthesiol Scand2004，48，2： | 1 |
| 19 | Adsorption and Association in Aqueous Solutions of Dissymmetric Gemini Surfactant显示文摘 | Maja S Ines P Nada F | 2002 | J Colloid & Interface Sci2002，250，： | 1 |
| 20 | Iron enriched yeast biomass: a promising mineral feed supplement显示文摘 | MAJA P BARBARA P MATEVZ S | 2007 | Bioresource Technology2007，98，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员